DUBLIN–(BUSINESS WIRE)–The “Europe Contact Lenses Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. European contact lenses market was valued at $2.23 billion in 2022 and is expected to grow at a CAGR of…
Author: Business Wire
Ophthalmics Collaboration and Licensing Agreements Analysis Report 2023 with a Directory of Deals Signed by the World's Leading Biopharma Companies Since 2016 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmics Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Fully revised and updated, the report provides details of ophthalmics deals from 2016 to 2023. Ophthalmic…
Berlin Cures advances fight against Long COVID on a pan-European level
BERLIN–(BUSINESS WIRE)–Berlin Cures, a biotechnology company specialized in neutralizing functional autoantibodies (fAABs), is expanding its Phase II clinical trial into a pan-European, multi-center collaboration in the fight against Long COVID. A to…
Delta Dental of Tennessee Launches Annual Holiday Campaign With $75,000 Pledge to Children's Hospitals Across Tennessee
NASHVILLE, Tenn.–(BUSINESS WIRE)–Delta Dental of Tennessee launched its annual holiday campaign, pledging a collective $75,000 in donations to children’s hospitals across the state.
Prevent Blindness Georgia Raises $320,000 To Expand Their Vision Saving Initiatives For Underserved Youth and Adults At 7TH Annual Night for Sight Gala
ATLANTA–(BUSINESS WIRE)–Prevent Blindness Georgia (PBGA), the state’s leading voluntary eye health organization dedicated to saving sight and restoring vision, is proud to share that it has successfully raised $320,000 to support its vision saving in…
BTIG to Host 3rd Annual Ophthalmology Day on November 27, 2023
NEW YORK–(BUSINESS WIRE)–BTIG announced today that its 3rd Annual Ophthalmology Day will take place on Monday, November 27, 2023. The virtual, one-day event will include thematic panel discussions, one-on-one meetings and company presentations. The e…
Harrow to Present at Two Investor Conferences in November
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following t…
Lunovus Enhances Its Eyecare Software and Service Solutions with Acquisition of Diamond Studios
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Lunovus LLC, a physician-owned pioneer in the eyecare industry, known for its advanced medical software and eye care supplementation solutions, has officially acquired Diamond Studios, a distinguished software develop…
VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through Third-Party Allotment.
KOBE, Japan–(BUSINESS WIRE)–VCCT Inc.(President: Masayo Takahashi) is pleased to announce the completion of a private equity allotment of approximately 600 million yen ($4 million USD). The allotment involved new shares to Sysmex Corporation (Preside…
Super Bowl MVP and Buffalo Bills Linebacker Von Miller, Teams up with Leading Optical Retailer GlassesUSA.com To Create Exclusive Eyewear Collection
NEW YORK CITY–(BUSINESS WIRE)–GlassesUSA.com, the leading online eyewear retailer in the United States, today announced the launch of the Von Miller x GlassesUSA.com eyewear collection, in collaboration with Super Bowl MVP and Buffalo Bills Linebacke…
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management …
LENZ Therapeutics and Graphite Bio Announce Merger Agreement
SAN DIEGO & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–LENZ Therapeutics, a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision, and Graphite Bio, Inc. (NASDAQ: GRPH) today announced …
Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and Biotrue Eye Care Recycling programs h…
Alcon Reports Third Quarter 2023 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Third Quarter 2023 Results
Global Protective Eyewear Strategic Research Report 2023: Market to Reach $3.8 Billion by 2030 – High-Growth Opportunities in the Military and Defense – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Protective Eyewear – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Protective Eyewear Market to Reach $3.8 Billion by 2030 The global market for Protective Eyewear est…
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
NEW YORK & LONDON–(BUSINESS WIRE)–Eyebiotech Limited (“EyeBio” or “the Company”), a privately held clinical-stage ophthalmology biotechnology company working to deliver a new generation of therapies for eye diseases, today announced the successful cl…
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today reported financial results for the third quar…
Harrow Announces Third Quarter 2023 Financial Results
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2023. The Company also posted its third quarter Letter to Sto…
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced financial results and provided a…
KeraLink International Provides $2.5 Million in Seed Funding to Enable Development of Bioengineered Corneal Implants
BALTIMORE–(BUSINESS WIRE)–KeraLink International invests in novel advancements to help eradicate corneal blindness globally, with emphasis on low- and middle-income countries.